Comorbidities in adult eczema
What’s real? What matters?
Keywords:
eczema, psoriasis , dermatitisAbstract
The observation that psoriasis may be an independent risk factor for myocardial infarction (MI) most famously elucidated in a population-based study from the UK published in JAMA, has been followed by a steady flow of studies on comorbidities of dermatologic diseases.
Psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, alopecia areata and more have been studied in relation to various extracutaneous comorbidities. Eczema, in particular, has been studied in relation to mental health and sleep disorders, cardiovascular disease and osteoporosis and fracture risk. In this article, I will review the evidence for selected adult eczema comorbidities and provide an opinion on whether each of them might change the way we manage patients. In other words, do they matter?
References
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735-1741.
Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. The Journal of Investigative Dermatology. 2015;135(1):56-66.
Garg N, Silverberg JI. Association between eczema and increased fracture and bone or joint injury in adults: a US population-based study. JAMA dermatology. 2015;151(1):33-41.
Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol. 2004;140(12):1513-1519.
Guttman-Yassky E, Silverberg JI, Nemoto O, et al. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. Journal of the American Academy of Dermatology. 2019;80(4):913-921 e919.
Simpson EL, Gadkari A, Worm M, et al. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). Journal of the American Academy of Dermatology. 2016;75(3):506-515.
Ronnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2018;79(3):448-456 e430.
Drucker AM, Thiruchelvam D, Redelmeier DA. Eczema and subsequent suicide: a matched case-control study. BMJ open. 2018;8(11):e023776.
McDonald K, Shelley A, Jafferany M. The PHQ-2 in Dermatology-Standardized Screening for Depression and Suicidal Ideation. JAMA Dermatology. 2017.
Thyssen JP, Halling-Overgaard AS, Andersen YMF, Gislason G, Skov L, Egeberg A. The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis. The British Journal of Dermatology. 2018;178(6):1272-1279.
Ascott A, Mulick A, Yu AM, et al. Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies. The Journal of Allergy and Clinical Immunology. 2019;143(5):1821-1829.
Silverwood RJ, Forbes HJ, Abuabara K, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ. 2018;361:k1786.
Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. Journal of the American Academy of Dermatology. 2015;72(4):606-616 e604.
Kantor R, Kim A, Thyssen JP, Silverberg JI. Association of atopic dermatitis with smoking: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2016;75(6):1119-1125 e1111.
Drucker AM, Harvey PJ. Atopic dermatitis and cardiovascular disease: What are the clinical implications? The Journal of Allergy and Clinical Immunology. 2019;143(5):1736-1738.
Lowe KE, Mansfield KE, Delmestri A, et al. Atopic eczema and fracture risk in adults: A population-based cohort study. The Journal of Allergy and Clinical Immunology. 2019.
Drucker AM, Eyerich K, de Brun-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. The British Journal of Dermatology. 2018;178(3):768-775.
